Subbu Venkatraman, PhD

National University of Singapore

Subbu Venkatraman obtained his Bachelor’s and Master’s degrees from India, then a PhD in Polymer Science from Carnegie-Mellon University, Pittsburgh. Following a post-doctoral fellowship at University of Pittsburgh, he was hired into the R&D organization of Raychem Corporation in California. He then went on to specialize in drug delivery research at two leading biotech companies, before joining NTU in 2000. He is the author of over 260 manuscripts, with over 8000 citations and a h-index of 45; he has authored 75 granted patents and another 15 patent applications worldwide. He is also the co-founder of three companies, Amaranth Medical, CardioRev and Peregrine Ophthalmic, specializing in therapeutic medical devices and drug delivery products. He won the Nanyang Award for Innovation in 2012, on the strength of his patented work on cardiovascular implants. In 2014, he was also awarded the Singapore President’s Technology Award for his innovative work on nanomedicine for glaucoma. He has won significant grants,including the Competitive Research Programme (CRP) grant (worth $10MM), the NTU-Technion Create grant (~$20MM) as well as several proof-of-concept grants totalling about $2MM He collaborates with clinician scientist, particularly ophthalmologists and interventional cardiologists. Currently, he is working on oral delivery of insulin.